Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$466,033,369
+$32,535,882 QoQ
Shares Held
9,721,180
-17.6% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#7
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. NVO ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $466,033,369 | 9,721,180 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $433,497,487 | 11,795,850 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $570,421,073 | 11,211,106 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $982,917,897 | 17,713,424 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $802,097,432 | 11,621,232 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $660,481,684 | 9,511,545 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $581,015,208 | 6,754,420 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $828,609,796 | 6,959,014 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $993,626,557 | 6,961,094 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $909,756,757 | 7,085,333 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $736,039,611 | 7,114,931 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $529,033,901 | 5,817,395 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $562,421,716 | 3,475,386 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $585,587,298 | 3,679,699 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $841,892,620 | 6,220,575 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $625,662,352 | 6,279,859 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $693,294,171 | 6,221,791 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $591,402,327 | 5,325,550 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $633,140,816 | 5,653,043 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $525,558,163 | 5,473,994 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $447,573,727 | 5,342,888 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $341,979,252 | 5,072,371 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $329,593,371 | 4,718,588 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $318,115,832 | 4,581,821 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $312,851,260 | 4,777,814 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $131,016,631 | 2,176,356 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||